US HB6174 | 2015-2016 | 114th Congress
Status
Spectrum: Slight Partisan Bill (Republican 2-1)
Status: Introduced on September 27 2016 - 25% progression, died in committee
Action: 2016-09-27 - Referred to the House Committee on Energy and Commerce.
Pending: House Energy And Commerce Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on September 27 2016 - 25% progression, died in committee
Action: 2016-09-27 - Referred to the House Committee on Energy and Commerce.
Pending: House Energy And Commerce Committee
Text: Latest bill text (Introduced) [PDF]
Summary
Closing Loopholes for Orphan Drugs Act This bill amends the Public Health Service Act to revise the 340B Drug Pricing Program, which currently requires drug manufacturers to discount orphan drugs (drugs for rare conditions) for certain entities covered by the program. The bill discounts orphan drugs that are not being used to treat rare conditions for all entities covered by the program.
Title
Closing Loopholes for Orphan Drugs Act
Sponsors
| Sen. Peter Welch [D-VT] | Rep. Morgan Griffith [R-VA] | Rep. Gregg Harper [R-MS] |
History
| Date | Chamber | Action |
|---|---|---|
| 2016-09-27 | House | Referred to the House Committee on Energy and Commerce. |
| 2016-09-27 | House | Introduced in House |
Subjects
US Congress State Sources
| Type | Source |
|---|---|
| Summary | https://www.congress.gov/bill/114th-congress/house-bill/6174/all-info |
| Text | https://www.congress.gov/114/bills/hr6174/BILLS-114hr6174ih.pdf |
